Peer Review History

Original SubmissionOctober 2, 2025
6. Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

Decision Letter - Afagh Hassanzadeh Rad, Editor

-->PONE-D-25-47161-->-->Driving factors in pediatric emergency department use: an ecological retrospective study-->-->PLOS ONE

Dear Dr. Mongin,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 10 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Afagh Hassanzadeh Rad

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section.

3. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

Please update your Data Availability statement in the submission form accordingly.

4. In the online submission form, you indicated that data will be made available upon request, conditioned to the approval of a proposal with a signed data access agreement and to the approval of the ethical commission concerned.

All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval.

5. We note that Figure 1, S2, in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figures 1, S2, to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

7. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: Partly

Reviewer #2: Yes

**********

-->2. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: I Don't Know

Reviewer #2: Yes

**********

-->3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: This manuscript represents a scientifically rigorous investigation, providing a clear and well-substantiated analysis of spatial variation in pediatric emergency department (PED) utilisation. The findings demonstrate that low-acuity visits are strongly modulated by socio-economic vulnerability and proximity to the hospital, whereas high-acuity visits remain largely unaffected by contextual factors. Notable strengths include the comprehensive two-year dataset, high-resolution geospatial and socio-demographic information, standardised CTAS triage, and the application of fully adjusted mixed-effects models. The limitations, including the retrospective ecological design, absence of individual-level health data, and restriction to a single urban centre, are appropriately acknowledged. To further enhance the manuscript, the authors should elaborate on the mechanistic pathways underlying the impact of socio-economic vulnerability, contextualise the findings relative to healthcare systems in other high-income settings, provide a summary table or figure of primary effects, clearly articulate policy implications, and explicitly delineate the novel contributions of this study in the context of existing literature

Reviewer #2: Authors must clearly state in Discussion and Conclusion that no individual-level inference can be drawn.

Rewrite interpretations to reflect neighborhood-level associations only.

Why was centroid distance preferred over population-weighted centroids or street-network distance?

If unique patients are used, explain whether a child with multiple visits counts once per CTAS category or once overall.

Clarify whether distance was measured “as the crow flies” or using travel time / road network.

Typographical errors:

“Halving diatnce” → “Halving distance”.

“Conterfactual” → “Counterfactual”.

“Geneva resident= 1 (%)” is unclear

Table 1 mixes visits and patients; columns unclear.

**********

-->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

Revision 1

Please see the attached document

Attachments
Attachment
Submitted filename: reviewer_JNS.docx
Decision Letter - Ilse Bloom, Editor

-->-->PONE-D-25-47161R1-->-->Driving factors in pediatric emergency department use: an ecological retrospective study-->-->PLOS One-->

Dear Dr. Mongin,

-->Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

  • The manuscript has been further evaluated by two reviewers, and their comments are available below.
  • Could you please carefully revise the manuscript to address all comments raised?

Please submit your revised manuscript by May 16 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors.

We look forward to receiving your revised manuscript.

Kind regards,

Ilse Bloom

Staff Editor

PLOS One

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.-->

Reviewer #1: (No Response)

Reviewer #3: (No Response)

**********

-->2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.-->

Reviewer #1: Yes

Reviewer #3: Yes

**********

-->3. Has the statistical analysis been performed appropriately and rigorously?-->

Reviewer #1: I Don't Know

Reviewer #3: Yes

**********

-->4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #3: Yes

**********

-->5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #3: Yes

**********

-->6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: Thank you for the opportunity to review this manuscript. The authors have adequately addressed the points raised in my previous comments, and I find the revisions satisfactory.

Reviewer #3: As the statistical reviewer I will focus on methods and reporting. note that this is the first time I see this paper. The methods are well described and appropriate. The key limitations, including ecological bias, are discussed. perhaps be more careful when you imply individual level inference at times.

Major

1) use an appropriate research checklist, e.g. STROBE probably in this case.

2) explain if all the data were complete for the analyses, are they likely are at this level.

Minor

1) How was pediatrician density operationalised

2) how was the NSVI index validated?

3) I'm not sure the "simulations" should be called that - they are model derived predictions under the same assumptions and "all else being equal". other than that, it is an appropriate approach.

4) perhaps also examine moran's I on the random effects as well, not only the residuals.

**********

-->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #1: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

-->

Revision 2

Reviewer #1: Thank you for the opportunity to review this manuscript. The authors have adequately addressed the points raised in my previous comments, and I find the revisions satisfactory.

Authors: we thank the reviewer for its positive feedback.

Reviewer #3: As the statistical reviewer I will focus on methods and reporting. note that this is the first time I see this paper. The methods are well described and appropriate. The key limitations, including ecological bias, are discussed. perhaps be more careful when you imply individual level inference at times.

Authors: We thank the reviewer for its positive feedback.

Major

1) use an appropriate research checklist, e.g. STROBE probably in this case.

Authors: We completed the STROBE checklist and uploaded it along the manuscript.

2) explain if all the data were complete for the analyses, are they likely are at this level.

Authors:

Data were complete, as they are aggregated data and administrative data.

We added to the result, section 3.2:

“No missing data were present in the aggregated data.”

Minor

1) How was pediatrician density operationalised

Authors: Thank you for raising this point. The operationalization of pediatrician density was described in the Methods section under 'Exposures of interest.' Specifically, we retrieved the addresses of all non-hospital pediatricians practicing in the Canton of Geneva from the Swiss Federal Register of Medical Professions [22]. Each address was then geocoded using the state geocoding API [20] to obtain precise geographic coordinates. Rather than computing a crude density per neighborhood, we adopted a spatial smoothing approach: for each neighborhood, we counted all pediatricians located within a fixed 2 km radius of the neighborhood centroid and expressed this as a density per 1,000 children. This radius-based approach is more representative of the actual availability of pediatricians from a family's perspective, as it captures the nearby supply of providers regardless of whether they happen to fall within the same administrative unit. We have reviewed and complemented this paragraph which now reads:

“Pediatrician density was derived from the Swiss Federal Register of Medical Professions [22] from which the addresses of all non-hospital pediatricians practicing in the Canton of Geneva were extracted. Each address was geocoded using the state geocoding API [20] to obtain precise geographic coordinates. For each neighborhood, the number of non-hospital pediatricians located within a fixed 2 km radius of the neighborhood centroid was counted and expressed per 1,000 children. This radius-based measure reflects the availability of pediatric primary care from a family's perspective, as it captures the nearby supply of providers irrespective of administrative boundaries.”

2) how was the NSVI index validated?

Authors: The NSVI has not undergone formal psychometric validation. It is a composite score developed by the “Centre d'analyse territorial des inégalités à Genève” (CATI-GE), a joint university–state institute dedicated to studying socio-economic inequalities in Geneva. The index is used operationally by cantonal authorities to allocate targeted funding to deprived neighborhoods, providing a degree of face and content validity. It has also been used in peer-reviewed research, including a study by our group on access to COVID-19 testing and outcomes, where it showed strong associations with both testing uptake and disease severity (Mongin et al., eClinicalMedicine 2022; doi:10.1016/j.eclinm.2022.101352). We have added a brief note in the Methods section acknowledging that the NSVI has not been formally validated but has demonstrated consistent associations with health outcomes in prior work:

“Socio-economic Status was assessed using the Neighborhood Socio-economic Vulnerability Index (NSVI), a composite score developed by the Centre d'analyse territorial des inégalités à Genève (CATI-GE), a joint university–state institute dedicated to studying socio-economic inequalities in Geneva [21], The NSVI ranges from 0 to 6 and is constructed from state-provided indicators including income, unemployment, and social benefits (full criteria are provided in Supplementary Table 1). Although the NSVI has not undergone formal psychometric validation, it is used operationally by cantonal authorities to guide the allocation of targeted funding to deprived neighborhoods, supporting its face and content validity. The index has also demonstrated consistent associations with health outcomes in prior peer-reviewed research, including a study conducted by our group in which higher NSVI scores were associated with reduced access to COVID-19 testing and worse disease outcomes [22].”

3) I'm not sure the "simulations" should be called that - they are model derived predictions under the same assumptions and "all else being equal". other than that, it is an appropriate approach.

Authors: We agree with the reviewer and have replaced ''counterfactual simulations' with 'counterfactual estimation’ throughout the manuscript to better reflect that these are derived from the fitted model under hypothetical conditions, holding all other factors constant.

4) perhaps also examine moran's I on the random effects as well, not only the residuals.

Authors: Thank you for this suggestion. We computed Moran's I on the estimated postal-code random intercepts for each CTAS level. Values were non-significant for CTAS 1 and CTAS 2, but significant for CTAS 3 (0.23, p<0.001) and CTAS 4* (0.16, p<0.05). This indicates that, for lower-acuity visits, some broad-scale spatial structure at the postal-code level remains unexplained by our exposure variables. This is not unexpected: while the exponential distance function captures the sharp, short-range proximity effect, broader geographic pattern, such as differences in urban fabric, transportation infrastructure, cultural composition, or the presence of alternative healthcare facilities, may vary smoothly across postal codes in ways not fully captured by our variable of interest. Importantly, Moran's I on the neighborhood-level residuals remained low and non-significant for all CTAS levels, confirming that the combination of fixed effects and postal-code random intercepts adequately accounts for spatial dependence at the analytical unit of interest. The spatial correlation in the random effects thus points to potential avenues for future research. These results have been added to the Results section:

“Residual spatial autocorrelation (Moran’s I) was below 0.1 and non-significant in all models, while spatial autocorrelation in the postal-code random intercepts was significant for CTAS 3 and 4* but below 0.3 (0.23 and 0.16 respectively).”

The corresponding values are reported in Table 2. We added in the discussion, in the paragraph about future work:

“Significant spatial autocorrelation in the postal-code random intercepts found in our study suggest that unmeasured spatially structured factors may contribute to variation in low-acuity PED use beyond the determinants considered here. Future studies should consider larger scale measurements, such as differences in transportation infrastructure, cultural composition, or the presence of alternative healthcare facilities.”

Attachments
Attachment
Submitted filename: reviewer.docx
Decision Letter - Helga Naburi, Editor

Driving factors in pediatric emergency department use: an ecological retrospective study

PONE-D-25-47161R2

Dear Dr. Denis Mongin,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Helga Naburi, MD, Mmed,MPH,PhD

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.-->

Reviewer #3: All comments have been addressed

**********

-->2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #3: Yes

**********

-->3. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #3: Yes

**********

-->4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #3: Yes

**********

-->5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #3: Yes

**********

-->6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #3: I am satisfied with the responses and the resulting changes to the paper. I have nothing else to add.

**********

-->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #3: No

**********

Formally Accepted
Acceptance Letter - Helga Naburi, Editor

PONE-D-25-47161R2

PLOS One

Dear Dr. Mongin,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Helga Naburi

Academic Editor

PLOS One

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .